3 research outputs found
Drug Review - Exemestane: A milestone against breast cancer
Rapid advances in the treatment of breast cancer, especially in the
form of hormone therapy have truly increased the hope of longer and
better disease-free survival for these patients. Exemestane, a third
generation aromatase inhibitor has been extensively evaluated in
metastatic as well as adjuvant therapy of breast cancer. It has also
been evaluated for its safety profile, especially on bone and lipids.
Exemestane provides hope to the patients with breast cancer both in
early and metastatic disease. This review analyzes all the aspects of
exemestane therapy